Introduction
Eosinophils are well known to have an important presence in allergic upper airway disease. In eosinophilic disorders of both the upper and lower airways, eosinophils had been long thought to be primarily end-stage effector cells, acting through the release of lipid mediators and granule-derived cationic proteins [1] . There is now a substantial body of evidence that has demonstrated that eosinophils have integral immunomodulatory functions in local inflammatory processes [2 ] . The increasingly recognized role of eosinophils as antigen-presenting cells (APCs) falls under this purview and is the subject of this review. The subject of eosinophils as APCs in allergic upper airway disease must be addressed somewhat obliquely, as specific studies focusing on the upper airways are limited. However, there is a substantial amount of evidence using models of lower airway allergic inflammation that is readily applicable to the upper airways, given the intimate links between upper and lower airway inflammation [3] . We will also discuss in-vitro evidence and studies of parasitic infection models that can be applied to elucidate possible eosinophil APC function in the upper airways.
Expression of major histocompatibility complex class II and costimulatory proteins
Eosinophils have long been recognized to be able to express major histocompatibility complex (MHC) class II, which is required for presentation of antigens derived from the extracellular environment [4, 5] . In vitro, the expression of MHC class II is dependent on stimulation of eosinophils by granulocyte macrophage colonystimulating factor (GM-CSF) [5] . A series of observations that eosinophils recovered from sites of allergic or parasitic inflammation expressed MHC class II is more immediately relevant to in-vivo disease [6] [7] [8] . A study by Sedgwick et al. [6] is specific to upper airway disease, in which patients with allergic rhinitis were exposed to segmental antigen challenge of the lower airways. Fourteen patients with rhinitis in the absence of asthma symptoms, who also had positive immediate skin response to ragweed antigen, were challenged with ragweed antigen. Eosinophils recovered from bronchoalveolar lavage fluid of the challenged segments had increased expression of MHC class II compared with peripheral blood eosinophils from these patients [6] . Similarly, in patients with asthma, eosinophils isolated from sputum expressed the MHC class II protein human leukocyte antigen (HLA)-DR, whereas eosinophils from peripheral blood did not [7] . In mouse models of parasitic infection, MHC class II was upregulated in eosinophils recovered from sites of infection [8] .
An in-vitro experiment by Yamamoto et al. [9] provided insight into the probable presence of activated eosinophils capable of antigen presentation in upper airway disease. In this experiment, an endothelial cell monolayer was cultured on transwells, and eosinophils isolated from peripheral blood were introduced to the upper chamber. Significant to the topic of this review, the source of eosinophils was peripheral blood of humans with allergic disease confirmed by immediate hypersensitivity skin testing. This group included patients with allergic rhinitis. Eosinophils that migrated through the transwells were observed to have higher expression of HLA-DR and improved survival compared with those eosinophils that did not migrate. These findings compellingly suggest that there are local eosinophils in allergic upper airway disease that are long-lived and have the requisite MHC class II to present antigen. On the basis of this experiment, one could speculate that the presence of these eosinophils is a key component of perpetuating local allergic inflammation of the upper airway mucosa.
MHC class II alone, however, is insufficient for professional antigen presentation; the presence of costimulatory molecules is necessary for cells to act as professional APCs, as defined by the ability to present antigen to naive T cells, resulting in their activation [10] . Ohkawara et al. [11] demonstrated that eosinophils isolated from the peripheral blood of mildly atopic patients express the costimulatory protein CD40. In addition, they made the key observations that eosinophils in lesional tissue from nasal polyps stain for CD40, and that CD40 mRNA is readily detectable in these specimens [11] . Two major costimulatory molecules, CD80 and CD86, have been shown in murine experimental models of allergic lower airway inflammation to be expressed on eosinophils recovered from airway sites of inflammation [12, 13] . CD80 and CD86 were also detectable on resting eosinophils recovered from the peritoneal cavities of IL-5 transgenic mice [14] . In addition, antigen-loaded murine eosinophils elicited proliferation of T cells in vitro that was inhibited by the presence of anti-CD80 and anti-CD86 antibodies [13, 14] . Human eosinophils from the peripheral blood of patients with hypereosinophilia have also been observed to express CD86 and CD28 [15] . Peripheral blood human eosinophils from normal individuals can be induced to express CD86 by IL-3 stimulation [16] . Table 1 [ [5] [6] [7] [8] [9] [11] [12] [13] [14] [15] [16] [17] [18] [19] summarizes key studies of MHC class II and costimulatory protein expression by human and murine eosinophils.
Eosinophils traffic to regional lymph nodes
Several studies have found that eosinophils traffic to regional lymph nodes after exposure to antigen, bringing them in proximity to T cells for antigen presentation. This was initially demonstrated by Shi et al. [13] who instilled eosinophils recovered from either IL-5 transgenic or airway allergen-challenged mice into the tracheas of wild-type mice. These fluorescently labeled eosinophils migrated to the paracortical T-cell zones of draining paratracheal lymph nodes, in which they were found to promote T-cell proliferation [13] . Interestingly, homing of eosinophils to draining lymph nodes was independent of the cardinal eosinophil chemotactic factors, the eotaxins, as the experimental findings were the same when eosinophils were harvested from mice deficient in chemokine (C-C motif) receptor 3 (CCR3), the eotaxin receptor [13] . It has been recently found that peripheral blood eosinophils pulsed with high concentrations of GM-CSF, IL-3, and IFNg exhibited chemotactic responses to the Eosinophils as antigen-presenting cells Akuthota et al. 15 [6] Human Airway eos express HLA-DR in allergic patients after segmental allergen challenge Hansel et al. [7] Human Sputum eos from asthmatic patients express HLA-DR Mawhorter et al. [8] Mouse Peritoneal eos express MHC class II in infection with Brugia malayi Yamamoto et al. [9] Human eos migrating through an endothelial cell layer express HLA-DR MacKenzie et al. [12] Mouse eos from allergen-challenged lung express MHC class II Shi et al. [13] Mouse eos from allergen-challenged lung express MHC class II Duez et al. [17] Mouse Lymph node eos in allergen-challenged mice express MHC class II Wang et al. [18] Mouse eos from IL-5 transgenic mice express HLA-DR Padigel et al. [19] Mouse eos pulsed with Strongyloides antigen upregulate MHC class II CD40 Ohkawara et al. [11] Human eos from allergic nasal mucosa express CD40 Wang et al. [18] Mouse eos from IL-5 transgenic mice express CD40 CD80, CD86
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chemokine chemokine (C-C motif) ligand 21 (CCL21) [20 ] . CCL21 is one of the major ligands of the receptor CCR7, and the interaction of CCL21 with CCR7 is pivotal in the homing of APCs, such as dendritic cells, and T cells to the paracortical T-cell zones of lymph nodes [21 ] . Although the eosinophils in this study were exposed in vitro to three cytokines, their response to CCL21 supports the functional responses of eosinophils as APCs.
Another study [22] utilizing intratracheal instillation of eosinophils from allergen-challenged mice demonstrated in vivo that eosinophils stimulated lymph node T cells to produce the Th2 cytokines such as IL-4, IL-5, and IL-13. The production of Th2 cytokines was significantly reduced when mice were administered mAbs against the costimulatory proteins, CD80 and CD86, further indicating that eosinophils were stimulating T cells through APC function [22] .
The migration of eosinophils to lymph nodes has been demonstrated with native eosinophils as well [17] . Sensitized mice that were challenged intranasally with allergen were found to have eosinophils in their draining lymph nodes [17] . Moreover, the eosinophils from the lymph nodes had greater expression of MHC class II and costimulatory molecules than those from other tissue compartments [17] .
Eosinophils function as antigen-presenting cells
As the above studies demonstrating the trafficking of eosinophils to lymph nodes suggest, not only do eosinophils express MHC class II and costimulatory molecules, but they also function as APCs. The APC function of eosinophils has been demonstrated in several older studies using in-vitro experimental models. Human eosinophils can process and present bee venom to antigenspecific T cells in coculture, causing their proliferation [23] . Similar results have been found using ovalbumin (OVA) and parasitic antigens as well as staphylococcal superantigens [24, 25] . Eosinophils loaded with tetanus toxoid were able to stimulate T-cell proliferation; this ability was preserved when eosinophils are fixed after antigen loading but not when eosinophils are fixed before antigen loading, indicating that eosinophils are actively processing antigen [26] . Although these studies are now several years old, they do represent valuable preliminary insights that provide contexts for the studies (described below) of eosinophils functioning as professional APCs. 
Eosinophils as professional antigen-presenting cells
It is important to emphasize that eosinophils function as true professional APCs. There is now a substantial body of evidence that demonstrates that eosinophils have the ability to stimulate naive T cells. Our group has recently specifically demonstrated the professional APC function of eosinophils in a murine model of lower airway allergic inflammation. Eosinophils isolated from the spleens of IL-5 transgenic mice were observed to express MHC class II, CD40, CD80, and CD86 when stimulated with GM-CSF [18] . GM-CSF-stimulated eosinophils were then loaded with OVA and instilled intratracheally into mice that had been intravenously administered naive OVA-specific T cells. Draining thoracic lymph nodes were harvested, and OVA-specific T cells were studied for markers of activation, proliferation, and cytokine production, indicators that eosinophils were functioning as professional APCs. Compared with control eosinophils that were not loaded with OVA, OVA-loaded eosinophils elicited marked increases in the expression of the activation marker CD69, proliferation, and production of IL-4 by T cells [18] . In addition, using fluorescent eosinophils, T cells, and OVA, eosinophils and T cells were observed in harvested lymph nodes to be physically interacting [18] .
A prior study [28] reported that murine eosinophils did not have the ability to prime naive T cells, a defining criterion Table 2 Antigen-presenting cell function by eosinophils: key evidence
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for professional APCs, and only had the ability to stimulate previously primed T cells. This study, however, was confounded by the method of eosinophil purification that exposed eosinophils (and not control dendritic cells) to ammonium chloride during erythrocyte lysis. Ammonium chloride is a classic inhibitor of antigen processing through its effect on preventing lysosomal acidification [29, 30] . As a part of our study, we directly compared the capacities of eosinophils, with and without exposure to ammonium chloride during their purification, to function as APCs. Intratracheal instillation of OVA-loaded eosinophils exposed to ammonium chloride for erythrocyte lysis resulted in a complete lack of T-cell stimulation, as opposed to robust stimulation seen when hypotonic saline was used for erythrocyte lysis during eosinophil purification [18] . That eosinophils exposed to ammonium chloride could not function as professional APCs explains both the prior reported failure of eosinophils to stimulate naive T cells and helps ascertain that antigen proteolysis and processing were active within eosinophils. Likewise, previous in-vitro coculture studies [23, 24] had provided compelling data that eosinophils actively process and present antigen. OVA and parasitic antigen processing and presentation by eosinophils were impaired by exposure to ammonium chloride and chloroquine, another inhibitor of lysosomal function [24] . Similar results were seen with bee venom-loaded eosinophils exposed to chloroquine [23] .
Eosinophils have also been demonstrated in models of parasitic infection to function as professional APCs and stimulate naive T cells [19, 27] . Padigel et al. [19] found that murine eosinophils pulsed with Strongyloides antigens upregulated their expression of MHC class II and costimulatory molecules and had the ability to stimulate IL-4 and IL-5 production in naive T cells. Furthermore, the ability of eosinophils to stimulate naive T cells in this experimental system was actually equivalent to that of dendritic cells [19] . The same group demonstrated that Strongyloides antigen-loaded eosinophils injected intraperitoneally migrated to the spleens of inoculated mice. Moreover, antigen-loaded eosinophils, but not antigenloaded eosinophils from MHC class II-deficient mice, primed spleen cells from recipient mice to produce IL-4 and IL-5 when re-exposed to antigen [27] .
Eosinophils demonstrate key organizational aspects of the cell surface antigen presentation complex that are characteristics of professional APCs. We have recently reported as an abstract that MHC class II in human eosinophils localizes to lipid rafts [31] , cholesterol-rich, and sphingolipid-rich membrane domains that mediate spatial organization of membrane proteins [32] . We observed in coculture in-vitro experiments that lipid raft integrity is essential to stimulation of T cells by eosinophils in a superantigen-mediated fashion (P. Akuthota, L.A. Spencer, A. Radke, P.F. Weller, unpublished data). Lipid raft disruption has been shown to impair APC function in other professional APCs [33, 34] . In addition, eosinophils abundantly express the membrane tetraspanin CD9 [35] , which has been demonstrated to mediate lateral membrane association of MHC class II molecules in murine dendritic cells [36] .
Contribution of IgE receptors to eosinophil antigen-presenting cell function?
The high-affinity IgE receptor, FceRI, was initially investigated on eosinophils as an important component of host defense against parasites [37] . However, it was subsequently observed to have a possible role in eosinophilic contribution to allergic upper airway disease [38] . Rajakulasingam et al. [38] noted in nasal biopsy specimens from allergen-challenged humans with allergic rhinitis that there was an increased expression of both FceRI mRNA and protein in rhinitis patients versus normal controls. Furthermore, a subset of the FceRI-expressing cells were eosinophils [38] . Similar upregulation of FceRI was reported in eosinophils from bronchoalveolar lavage fluid of patients with atopic asthma challenged with allergen [39] . Recent studies from our laboratory of murine eosinophils with humanized FceRI demonstrate the possible relevance of these findings on the APC function of eosinophils (H. Wang, J. Kinet, P.F. Weller, unpublished data). Murine eosinophils expressing human FceRI had increased expression of costimulatory molecules with FceRI cross-linking. Additionally, intratracheally instilled eosinophils migrated to lymph nodes and stimulated antigen-specific T-cell proliferation more efficiently when pretreated with antigen-hapten complex and hapten-specific IgE compared with pretreatment with antigen-hapten alone. These findings support the importance of high-affinity IgE receptor in antigen processing and presentation by eosinophils. We also previously reported in an abstract form that the lowaffinity IgE receptor, FceRII, might also be contributing to antigen presentation by murine eosinophils in a similar in-vivo experimental system [40] .
Conclusion
The last several years have seen an extensive challenge to the traditional view of eosinophils as solely end-stage effector granulocytes. Mounting evidence has dramatically expanded the role that eosinophils are thought to have in inflammatory processes, including a wealth of data that support their function as APCs. Eosinophils express the necessary MHC class II and costimulatory proteins for antigen presentation, are able to traffic to draining lymph nodes in which they encounter T cells, and function as true professional APCs with the ability to stimulate both previously primed and naive T cells.
Although much of the functional data regarding eosinophils as APCs do not specifically use upper airway allergic disease as a model, there is sufficient evidence of eosinophils of atopic patients expressing MHC class II, costimulatory proteins, and IgE receptor to strongly suggest that findings from animal models of lower airway allergen challenge are applicable to the upper airways as well. One may speculate as to the true nature of eosinophil APC function in allergic disease. Eosinophil APC function may not be redundant to that of traditional APCs but may be responsible for initiation and amplification of allergic responses to a discrete set of allergens. Future studies that focus on eosinophils recovered from the upper airways from both atopic humans and experimental animals are necessary to continue to expand the evidence in support of eosinophils as APCs in allergic upper airway disease.
